A study of 2,470 patients with type 2 diabetes and early-stage chronic kidney disease across two U.S. health systems found that the KidneyIntelX test significantly improves kidney function outcomes over 24 months. The test helps doctors tailor treatments, increasing use of guideline-recommended therapies like SGLT2 inhibitors and GLP-1 receptor agonists, especially in high-risk patients. Nearly 30% of patients moved to a lower risk category, with measurable improvements in kidney biomarkers and reduced disease progression. This real-world evidence supports KidneyIntelX as a dynamic tool that not only predicts risk but also guides effective treatment to slow kidney decline.
Cause + Effect Strategy (CES) and StackAI have formed a strategic partnership to help mid-market and enterprise organizations implement AI solutions that deliver real business outcomes. CES brings expertise in data strategy and analytics infrastructu...
Aikido Security has acquired Root to improve the security of open source software by enabling AI agents to research, patch, and test vulnerabilities without forcing teams to upgrade or migrate. This approach addresses the growing threat of supply cha...
Nutanix has donated $250,000 to the North Carolina School of Science and Mathematics (NCSSM) to establish an endowed professorship aimed at expanding computer science education across North Carolina. This funding supports teacher training and open-so...
Wetour Robotics has demonstrated its Conductor neural wristband that converts wrist muscle signals into a real-time 3D digital twin of the hand and translates hand gestures into text commands without cameras or gloves. This technology, built on Meta'...
DLP Real Estate Capital closed a $118 million refinancing deal for its Houston multifamily portfolio, which includes 605 units across two communities: Elan Memorial and City Park in the Heights. The new floating-rate loan has a 36-month term with ext...
